Eli Lilly and Company
LLY
$732.41
$11.501.60%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 18.30% | 1.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 18.30% | 1.21% | |||
| Cost of Revenue | 10.73% | 0.03% | |||
| Gross Profit | 20.08% | 1.49% | |||
| SG&A Expenses | 16.34% | -0.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.28% | 0.07% | |||
| Operating Income | 27.43% | 2.97% | |||
| Income Before Tax | 217.22% | -54.84% | |||
| Income Tax Expenses | 1.75% | 12.34% | |||
| Earnings from Continuing Operations | 354.48% | -67.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 354.48% | -67.30% | |||
| EBIT | 27.43% | 2.97% | |||
| EBITDA | 25.24% | 3.80% | |||
| EPS Basic | 353.39% | -67.30% | |||
| Normalized Basic EPS | 27.25% | 2.80% | |||
| EPS Diluted | 356.29% | -67.38% | |||
| Normalized Diluted EPS | 27.81% | 2.71% | |||
| Average Basic Shares Outstanding | 0.24% | 0.01% | |||
| Average Diluted Shares Outstanding | -0.20% | 0.09% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.78% | 2.05% | |||
